1-5 of 5
Manuela Zanni
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma

Clinical Trials & Observations
Annarita Conconi, Annalisa Chiappella, Andrés J. M. Ferreri, Anastasios Stathis, Barbara Botto, Marianna Sassone, Gianluca Gaidano, Monica Balzarotti, Francesco Merli, Alessandra Tucci, Anna Vanazzi, Monica Tani, Riccardo Bruna, Lorella Orsucci, Maria Giuseppina Cabras, Melania Celli, Ombretta Annibali, Anna Marina Liberati, Manuela Zanni, Chiara Ghiggi, Francesco Pisani, Graziella Pinotti, Fausto Dore, Fabiana Esposito, Maria Cristina Pirosa, Marina Cesaretti, Luisella Bonomini, Umberto Vitolo, Emanuele Zucca
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1541–1549.
https://doi.org/10.1182/bloodadvances.2023011251
Published: 2024
Journal Articles

A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
Annalisa Arcari, Lugi Rigacci, Alessandra Tucci, Benedetta Puccini, Sara Veronica Usai, Federica Cavallo, Alberto Fabbri, Monica Balzarotti, Sabrina Pelliccia, Stefano Luminari, Elsa Pennese, Vittorio Ruggero Zilioli, Abdurraouf Mokhtar Mahmoud, Gerardo Musuraca, Dario Marino, Roberto Sartori, Barbara Botto, Guido Gini, Manuela Zanni, Stefan Hohaus, Giuseppe Tarantini, Leonardo Flenghi, Monica Tani, Alice Di Rocco, Michele Merli, Daniele Vallisa, Chiara Pagani, Luca Nassi, Daniela Dessì, Simone Ferrero, Emanuele Cencini, Patrizia Bernuzzi, Caterina Mammi, Luigi Marcheselli, Valentina Tabanelli, Michele Spina, Francesco Merli
Journal: Blood Advances
Blood Adv (2023) 7 (15): 4160–4169.
https://doi.org/10.1182/bloodadvances.2023009839
Published: 2023
Includes: Supplemental data
Journal Articles

Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL

Clinical Trials & Observations
Maria Chiara Tisi, Riccardo Moia, Caterina Patti, Andrea Evangelista, Simone Ferrero, Michele Spina, Monica Tani, Barbara Botto, Melania Celli, Benedetta Puccini, Emanuele Cencini, Alice Di Rocco, Claudio Chini, Chiara Ghiggi, Renato Zambello, Manuela Zanni, Roberta Sciarra, Riccardo Bruna, Martina Ferrante, Stefano Alessandro Pileri, Francesca Maria Quaglia, Caterina Stelitano, Alessandro Re, Stefano Volpetti, Vittorio Ruggero Zilioli, Annalisa Arcari, Francesco Merli, Carlo Visco
Journal: Blood Advances
Blood Adv (2023) 7 (15): 3916–3924.
https://doi.org/10.1182/bloodadvances.2023009744
Published: 2023
Includes: Supplemental data
Journal Articles

Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial

Clinical Trials & Observations
Umberto Ricardi, Mario Levis, Andrea Evangelista, Daniela Maria Gioia, Gian Mauro Sacchetti, Manuel Gotti, Alessandro Re, Michela Buglione, Vincenzo Pavone, Antonio Nardella, Luca Nassi, Manuela Zanni, Paola Franzone, Giovanni Piero Frezza, Alessandro Pulsoni, Lavinia Grapulin, Armando Santoro, Luigi Rigacci, Gabriele Simontacchi, Monica Tani, Francesco Zaja, Elisabetta Abruzzese, Barbara Botto, Vittorio Ruggero Zilioli, Delia Rota-Scalabrini, Roberto Freilone, Giovannino Ciccone, Andrea Riccardo Filippi, Pier Luigi Zinzani
Journal: Blood Advances
Blood Adv (2021) 5 (21): 4504–4514.
https://doi.org/10.1182/bloodadvances.2021005150
Published: 2021
Includes: Supplemental data
Journal Articles

Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma

Clinical Trials & Observations
Armando Santoro, Rita Mazza, Alessandro Pulsoni, Alessandro Re, Maurizio Bonfichi, Vittorio Ruggero Zilioli, Manuela Zanni, Francesco Merli, Antonella Anastasia, Stefano Luminari, Giorgia Annechini, Manuel Gotti, Annalisa Peli, Anna Marina Liberati, Nicola Di Renzo, Luca Castagna, Laura Giordano, Francesca Ricci, Carmelo Carlo-Stella
Journal: Blood Advances
Blood Adv (2020) 4 (1): 136–140.
https://doi.org/10.1182/bloodadvances.2019000984
Published: 2020
Includes: Supplemental data